Medical Health Cluster


New Guidance on Neurological Complications of Long-COVID

The American Academy of Physical Medicine and Rehabilitation (AAPM&R) has issued new consensus guidance on the assessment and treatment of neurologic sequelae in patients with long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC). The new recommendations, which were published online May 16 in Physical Medicine & Rehabilitation, […]

Read More

Molnupiravir Reduces COVID-19–Associated Mortality and Risk for Long COVID

When started within 5 days after symptom onset, molnupiravir lowered risk for post-acute death and long-COVID sequelae regardless of vaccination status or reinfection. Long COVID is a multifaceted condition with persistent post-acute and chronic sequelae. Previous reports indicated that full vaccination and antiviral treatment with nirmatrelvir/ritonavir (Paxlovid) were both associated […]

Read More

Presence of Autoantibodies Most Predictive of Long COVID in Study

A deep molecular dive into COVID-19 patients found that the presence of autoantibodies in peripheral blood at initial diagnosis was the chief of four risk factors predicting if a patient would experience long COVID. Other significant early predictors of prolonged COVID symptoms – which the researchers called postacute sequelae – […]

Read More